211 related articles for article (PubMed ID: 20418051)
1. Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006.
Nosyk B; Marsh DC; Sun H; Schechter MT; Anis AH
J Subst Abuse Treat; 2010 Jul; 39(1):22-31. PubMed ID: 20418051
[TBL] [Abstract][Full Text] [Related]
2. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
Peles E; Schreiber S; Adelson M
Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
[TBL] [Abstract][Full Text] [Related]
3. Physician peer assessments for compliance with methadone maintenance treatment guidelines.
Strike C; Wenghofer E; Gnam W; Hillier W; Veldhuizen S; Millson M
J Contin Educ Health Prof; 2007; 27(4):208-13. PubMed ID: 18085599
[TBL] [Abstract][Full Text] [Related]
4. Proportional hazards frailty models for recurrent methadone maintenance treatment.
Nosyk B; MacNab YC; Sun H; Fischer B; Marsh DC; Schechter MT; Anis AH
Am J Epidemiol; 2009 Sep; 170(6):783-92. PubMed ID: 19671835
[TBL] [Abstract][Full Text] [Related]
5. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
[TBL] [Abstract][Full Text] [Related]
6. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
[TBL] [Abstract][Full Text] [Related]
7. Methadone dosage and retention: an examination of the 60 mg/day threshold.
Brady TM; Salvucci S; Sverdlov LS; Male A; Kyeyune H; Sikali E; DeSale S; Yu P
J Addict Dis; 2005; 24(3):23-47. PubMed ID: 16186081
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
9. Correlation between high methadone doses and methadone serum levels in methadone maintenance treatment (MMT) patients.
Adelson M; Peles E; Bodner G; Kreek MJ
J Addict Dis; 2007; 26(1):15-26. PubMed ID: 17439864
[TBL] [Abstract][Full Text] [Related]
10. Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002.
Bell J; Burrell T; Indig D; Gilmour S
Drug Alcohol Depend; 2006 Jan; 81(1):55-61. PubMed ID: 15993552
[TBL] [Abstract][Full Text] [Related]
11. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
12. [Personality changes in opioid-dependent subjects in a methadone maintenance treatment program].
Trémeau F; Darreye A; Leroy B; Renckly V; Ertlé S; Weibel H; Khidichian F; Macher JP
Encephale; 2003; 29(4 Pt 1):285-92. PubMed ID: 14615698
[TBL] [Abstract][Full Text] [Related]
13. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
14. Retention in methadone maintenance treatment in mainland China, 2004-2012: a literature review.
Zhou K; Zhuang G
Addict Behav; 2014 Jan; 39(1):22-9. PubMed ID: 24090627
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence.
Strike CJ; Gnam W; Urbanoski K; Fischer B; Marsh DC; Millson M
Addict Behav; 2005 Jun; 30(5):1025-8. PubMed ID: 15893099
[TBL] [Abstract][Full Text] [Related]
16. Predictors of early dropout in methadone maintenance treatment program in Yunnan province, China.
Che Y; Assanangkornchai S; McNeil E; Chongsuvivatwong V; Li J; Geater A; You J
Drug Alcohol Rev; 2010 May; 29(3):263-70. PubMed ID: 20565518
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of long QTc interval in methadone maintenance patients.
Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
[TBL] [Abstract][Full Text] [Related]
18. Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study.
Nosyk B; Sun H; Evans E; Marsh DC; Anglin MD; Hser YI; Anis AH
Addiction; 2012 Sep; 107(9):1621-9. PubMed ID: 22385013
[TBL] [Abstract][Full Text] [Related]
19. The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting.
Nolan S; Hayashi K; Milloy MJ; Kerr T; Dong H; Lima VD; Lappalainen L; Montaner J; Wood E
Drug Alcohol Depend; 2015 Nov; 156():57-61. PubMed ID: 26455554
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
Peles E; Schreiber S; Adelson M
Drug Alcohol Depend; 2006 May; 82(3):211-7. PubMed ID: 16219428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
